NICAISE CLAUDE 1644162 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Nicaise Claude | DIRECTOR | acq | 1846.0 | 10.16 | 0.2 | 0.0 | Direct | Common Stock | SAREPTA THERAPEUTICS, INC. | code A | 18174.0 | 93.55 (SRPT) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-26 | 2023-06-23 | 2023-06-23 | 4 | Nicaise Claude | DIRECTOR | acq | 10500.0 | 100.0 | 8.52 | 4.5 | Direct | Stock Option (Right To Buy) | GAIN THERAPEUTICS, INC. | code A | 10500.0 | 12.33 (GANX) |
| 2023-12-08 | 2023-12-06 | 2023-12-06 | 4 | Nicaise Claude | DIRECTOR | acq | 20000.0 | 100.0 | 4.74 | 21.71 | Direct | Stock Option (Right To Buy) | CASSAVA SCIENCES INC | code A | 20000.0 | 42.17 (SAVA) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Nicaise Claude | DIRECTOR | acq | 3679.0 | 100.0 | 0.39 | 128.67 | Direct | Stock Option (Right To Buy) | SAREPTA THERAPEUTICS, INC. | code A | 3679.0 | 93.55 (SRPT) |
| 2024-05-13 | 2024-05-09 | 2024-05-09 | 4 | Nicaise Claude | DIRECTOR | acq | 10000.0 | 100.0 | 2.08 | 21.11 | Direct | Stock Option (Right To Buy) | CASSAVA SCIENCES INC | code A | 10000.0 | 47.98 (SAVA) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)